Cadila Healthcare has entered into an agreement to invest in the equity shares of Windlass Healthcare (WHPL), for acquiring 51% share capital of Windlass. WHPL is engaged in the business of pharmaceuticals.
The main objective of this investment is to expand Pharma manufacturing footprint. The acquisition will be completed by end of September 2018. The cost of acquisition is Rs 155.55 crore.
Cadila Healthcare is an India-based pharmaceutical company. The company's subsidiaries include Zydus Wellness, Liva Pharmaceuticals, Biochem Pharmaceutical Industries, Zydus Technologies, German Remedies, Dialforhealth India, Dialforhealth Unity and Dialforhealth Greencross, among others.
